Indian Company Master Data Made Simple
Search:
MCA
GSTIN
LEI
Udyam
Directors
36+ lakh companies in our registry
Bal Pharma Limited
Bal Pharma Limited, founded in 1987, carries 39 years of experience in its sector. Corporate Identification Number is L85110KA1987PLC008368 and its registration number is 8368. The organization is recorded as company limited by shares under Indian company law. The company has an authorized share capital of ₹20.00 crore. This company’s paid-up capital is valued at ₹15.92 crore.
Its principal business sector is human health activities. Bal Pharma Limited is officially registered in Bangalore. The firm’s incorporation address reads 21-22, Bommasandra, Industrial Area, Bommasandra Industrial Estate, Bangalore, Bangalore South, Karnataka, India, 560099. Bal Pharma Limited remains active and operational. Bal Pharma Limited is registered with the PAN code AABCB0512E. Bal Pharma Limited is identified globally under LEI 254900F3KMK38GUDIW74. All official communications can be sent to secretarial@balpharma.com. Bal Pharma Limited’s leadership roster features Daddanala Venkat Bharath Bhushan (CFO).
Company Overview
- CIN
- Date of Incorporation
- 19/05/1987
- Company Status
- Active
- RoC
- Bangalore
- Registration Number
- Balance sheet date
- 31/03/2024
- Company Category
- Company limited by shares
- Company Sub Category
- Non-government company
- Listed in Stock Exchange
- Yes
- Class of Company
- Public Limited Company
- LEI Number
- LEI Status
- Issued
- Authorized Capital
- ₹20,00,00,000.00
- Paid up Capital
- ₹15,92,08,720.00
- Activity
- Human health activities
- secretarial@balpharma.com
- PAN
GST Numbers
| State | GST Number | Status |
|---|---|---|
| Bihar | 10AABCB0512E1ZU | Inactive |
| Chandigarh | 04AABCB0512E1ZN | Inactive |
| Delhi | 07AABCB0512E1ZH | Active |
| Gujarat | 24AABCB0512E1ZL | Inactive |
| Haryana | 06AABCB0512E1ZJ | Inactive |
| 06AABCB0512E3ZH | Inactive | |
| 06AABCB0512E2ZI | Active | |
| Jharkhand | 20AABCB0512E1ZT | Active |
| Kerala | 32AABCB0512E1ZO | Inactive |
| Karnataka | 29AABCB0512E1ZB | Active |
ISIN Numbers
| ISIN | Security | Interest Rate | Maturity Date | FISN | CFI |
|---|---|---|---|---|---|
| INE083D01012 | BAL PHARMA LIMITED EQ | - | 12/10/2026 | BAL PHARMA/SH VTG | ESVUFN |
| IN8083D01011 | BAL PHARMA LIMITED EQ LISTING/TRADING APPROVAL AWAITED | - | 12/10/2026 | BAL PHARMA/SH VTG | ESVUFN |
Balance Sheet
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| Net PPE | ₹8,524.23L | ₹7,536.65L | ₹6,695.97L | ₹6,419.92L | ₹0.00L |
| Net Debt | ₹15,721.55L | ₹14,862.86L | ₹13,540.33L | ₹12,951.22L | ₹0.00L |
| Goodwill | ₹382.69L | ₹382.69L | ₹382.69L | ₹382.86L | ₹0.00L |
| Gross PPE | ₹14,393.94L | ₹7,377.63L | ₹11,282.60L | ₹10,336.27L | ₹0.00L |
| Inventory | ₹11,635.54L | ₹10,302.22L | ₹8,781.15L | ₹9,800.50L | ₹0.00L |
| Total Debt | ₹16,660.99L | ₹15,041.32L | ₹14,225.04L | ₹13,307.92L | ₹0.00L |
| Common Stock | ₹1,592.09L | ₹1,592.09L | ₹1,580.44L | ₹1,568.99L | ₹0.00L |
| Current Debt | ₹12,763.17L | ₹11,899.98L | ₹10,324.96L | ₹10,047.62L | ₹0.00L |
| Share Issued | ₹159.21L | ₹159.21L | ₹158.04L | ₹156.90L | ₹0.00L |
| Total Assets | ₹37,553.98L | ₹33,569.03L | ₹31,983.83L | ₹31,317.23L | ₹0.00L |
| Capital Stock | ₹1,592.09L | ₹1,592.09L | ₹1,580.44L | ₹1,568.99L | ₹0.00L |
| Long Term Debt | ₹3,188.48L | ₹3,141.34L | ₹3,634.94L | ₹3,052.31L | ₹0.00L |
| Current Assets | ₹26,223.35L | ₹23,487.20L | ₹23,416.16L | ₹22,815.59L | ₹0.00L |
| Prepaid Assets | ₹2,805.70L | ₹2,205.18L | ₹2,084.86L | ₹2,331.69L | ₹0.00L |
| Working Capital | ₹1,300.56L | ₹1,537.17L | ₹3,110.44L | ₹1,882.15L | ₹0.00L |
| Invested Capital | ₹24,174.40L | ₹22,779.61L | ₹21,160.34L | ₹19,478.84L | ₹0.00L |
| Other Properties | ₹7,675.15L | ₹7,099.05L | ₹6,160.51L | ₹6,217.92L | ₹0.00L |
| Retained Earnings | ₹3,168.35L | ₹2,731.03L | ₹2,205.21L | ₹1,468.86L | ₹0.00L |
| Common Stock Equity | ₹8,222.75L | ₹7,741.59L | ₹7,200.44L | ₹6,378.91L | ₹0.00L |
| Net Tangible Assets | ₹6,497.81L | ₹6,159.15L | ₹5,679.62L | ₹4,950.35L | ₹0.00L |
| Tangible Book Value | ₹6,497.81L | ₹6,159.15L | ₹5,679.62L | ₹4,950.35L | ₹0.00L |
| Current Liabilities | ₹24,922.79L | ₹21,950.03L | ₹20,305.72L | ₹20,933.44L | ₹0.00L |
| Long Term Provisions | ₹620.16L | ₹564.46L | ₹508.60L | ₹506.75L | ₹0.00L |
| Stockholders Equity | ₹8,222.75L | ₹7,741.59L | ₹7,200.44L | ₹6,378.91L | ₹0.00L |
| Other Equity Interest | ₹6,630.65L | ₹6,149.50L | ₹66.55L | ₹139.26L | ₹0.00L |
| Total Capitalization | ₹11,411.23L | ₹10,882.93L | ₹10,835.38L | ₹9,431.22L | ₹0.00L |
| Ordinary Shares Number | ₹159.21L | ₹159.21L | ₹158.04L | ₹156.90L | ₹0.00L |
| Other Intangible Assets | ₹1,342.25L | ₹1,199.75L | ₹1,138.13L | ₹1,045.70L | ₹0.00L |
| Other Non Current Assets | ₹17.11L | ₹17.08L | ₹17.76L | ₹24.22L | ₹0.00L |
| Total Non Current Assets | ₹11,330.63L | ₹10,081.83L | ₹8,567.67L | ₹8,501.64L | ₹0.00L |
| Cash And Cash Equivalents | ₹230.10L | ₹175.16L | ₹419.57L | ₹148.71L | ₹0.00L |
| Construction In Progress | ₹849.08L | ₹437.56L | ₹264.93L | ₹201.99L | ₹0.00L |
| Accumulated Depreciation | -₹5,869.71L | ₹0.00L | -₹4,586.63L | -₹3,916.35L | -₹3,468.55L |
| Additional Paid In Capital | ₹3,197.79L | ₹0.00L | ₹3,128.75L | ₹3,018.39L | ₹2,667.66L |
| Other Short Term Investments | ₹690.65L | ₹865.86L | ₹1,573.33L | ₹597.56L | ₹0.00L |
| Other Non Current Liabilities | -₹0.02L | -₹0.01L | -₹0.01L | -₹0.01L | ₹0.00L |
| Machinery Furniture Equipment | ₹8,088.72L | ₹0.00L | ₹6,717.34L | ₹6,130.77L | ₹5,580.52L |
| Goodwill And Other Intangible Assets | ₹1,724.94L | ₹1,582.44L | ₹1,520.82L | ₹1,428.56L | ₹0.00L |
| Total Equity Gross Minority Interest | ₹8,225.25L | ₹7,740.44L | ₹7,197.15L | ₹6,370.22L | ₹0.00L |
| Total Liabilities Net Minority Interest | ₹29,328.73L | ₹25,828.59L | ₹24,786.68L | ₹24,947.01L | ₹0.00L |
| Current Debt And Capital Lease Obligation | ₹12,911.30L | ₹11,899.98L | ₹10,452.68L | ₹10,133.11L | ₹0.00L |
| Long Term Debt And Capital Lease Obligation | ₹3,749.69L | ₹3,141.34L | ₹3,772.36L | ₹3,174.81L | ₹0.00L |
| Cash Cash Equivalents And Short Term Investments | ₹920.75L | ₹1,041.02L | ₹1,992.90L | ₹746.27L | ₹0.00L |
| Total Non Current Liabilities Net Minority Interest | ₹4,405.94L | ₹3,878.56L | ₹4,480.96L | ₹4,013.57L | ₹0.00L |
Cash Flow
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 |
|---|---|---|---|---|
| Free Cash Flow | ₹845.54L | ₹152.83L | ₹1,182.58L | -₹1,618.25L |
| Changes In Cash | ₹54.96L | -₹244.42L | ₹270.86L | ₹37.43L |
| End Cash Position | ₹230.11L | ₹175.16L | ₹419.58L | ₹148.71L |
| Financing Cash Flow | -₹958.64L | -₹784.24L | -₹120.63L | ₹2,409.38L |
| Investing Cash Flow | -₹2,069.94L | -₹1,491.69L | -₹1,889.09L | -₹2,218.24L |
| Operating Cash Flow | ₹3,083.54L | ₹2,031.51L | ₹2,280.58L | -₹153.71L |
| Capital Expenditure | -₹2,238.00L | -₹1,878.68L | -₹1,098.00L | -₹1,464.54L |
| Beginning Cash Position | ₹175.16L | ₹419.58L | ₹148.71L | ₹111.27L |
| Issuance Of Capital Stock | ₹0.00L | ₹14.12L | ₹50.12L | ₹391.71L |
| Other Cash Adjustment Outside Changein Cash | -₹0.01L | ₹0.01L | ₹0.01L | ₹0.01L |
Income Statement
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| EBIT | ₹2,081.65L | ₹1,967.56L | ₹2,195.19L | ₹1,524.45L | ₹0.00L |
| EBITDA | ₹3,189.58L | ₹2,944.66L | ₹3,360.08L | ₹2,437.28L | ₹0.00L |
| Basic EPS | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Income | ₹628.36L | ₹721.54L | ₹739.22L | ₹257.17L | ₹0.00L |
| Diluted EPS | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Gross Profit | ₹14,082.03L | ₹13,299.43L | ₹13,115.90L | ₹12,546.34L | ₹0.00L |
| Pretax Income | ₹593.39L | ₹513.74L | ₹904.73L | ₹474.85L | ₹0.00L |
| Tax Provision | -₹38.62L | -₹209.92L | ₹160.16L | ₹212.92L | ₹0.00L |
| Total Revenue | ₹30,297.91L | ₹29,427.31L | ₹33,921.96L | ₹30,170.73L | ₹0.00L |
| Cost Of Revenue | ₹16,215.88L | ₹16,127.88L | ₹19,518.60L | ₹17,624.39L | ₹0.00L |
| Total Expenses | ₹28,006.30L | ₹27,417.16L | ₹30,457.01L | ₹28,416.23L | ₹0.00L |
| Interest Income | ₹95.33L | ₹0.00L | ₹55.96L | ₹23.13L | ₹37.01L |
| Interest Expense | ₹1,488.26L | ₹1,453.82L | ₹1,448.23L | ₹1,049.60L | ₹0.00L |
| Operating Income | ₹2,291.61L | ₹2,010.15L | ₹2,177.49L | ₹1,754.50L | ₹0.00L |
| Tax Rate For Calcs | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Normalized EBITDA | ₹3,178.28L | ₹2,943.31L | ₹3,360.08L | ₹2,423.99L | ₹0.00L |
| Normalized Income | ₹621.58L | ₹720.59L | ₹731.64L | ₹247.04L | ₹0.00L |
| Operating Expense | ₹11,790.42L | ₹11,289.28L | ₹10,938.41L | ₹10,791.84L | ₹0.00L |
| Operating Revenue | ₹30,297.91L | ₹29,427.31L | ₹32,634.50L | ₹30,170.73L | ₹0.00L |
| Net Interest Income | -₹1,607.12L | -₹1,605.41L | -₹1,410.58L | -₹1,208.25L | ₹0.00L |
| Total Unusual Items | ₹11.30L | ₹1.35L | ₹8.27L | ₹13.29L | ₹0.00L |
| Basic Average Shares | ₹159.20L | ₹158.53L | ₹157.38L | ₹156.90L | ₹0.00L |
| Diluted Average Shares | ₹159.20L | ₹158.53L | ₹157.38L | ₹156.90L | ₹0.00L |
| Total Other Finance Cost | ₹214.19L | ₹251.62L | ₹176.08L | ₹181.78L | ₹0.00L |
| Other Operating Expenses | ₹2,615.94L | ₹2,448.87L | ₹2,856.42L | ₹2,658.95L | ₹0.00L |
| Reconciled Depreciation | ₹1,107.93L | ₹977.09L | ₹1,007.11L | ₹912.83L | ₹0.00L |
| Reconciled Cost Of Revenue | ₹16,215.88L | ₹16,127.88L | ₹19,518.60L | ₹17,624.39L | ₹0.00L |
| Rent Expense Supplemental | ₹83.73L | ₹100.80L | ₹104.92L | ₹76.36L | ₹0.00L |
| Tax Effect Of Unusual Items | ₹4.52L | ₹0.41L | ₹0.69L | ₹3.16L | ₹0.00L |
| Interest Income Non Operating | ₹95.33L | ₹0.00L | ₹55.96L | ₹23.13L | ₹37.01L |
| Selling And Marketing Expense | ₹1,723.50L | ₹1,939.30L | ₹1,744.65L | ₹1,477.41L | ₹0.00L |
| Interest Expense Non Operating | ₹1,488.26L | ₹1,453.82L | ₹1,448.23L | ₹1,049.60L | ₹0.00L |
| Net Income Common Stockholders | ₹628.36L | ₹721.54L | ₹739.22L | ₹257.17L | ₹0.00L |
| Net Income Continuous Operations | ₹632.01L | ₹723.67L | ₹744.58L | ₹261.93L | ₹0.00L |
| Diluted NIAvailto Com Stockholders | ₹628.36L | ₹721.53L | ₹739.22L | ₹257.17L | ₹0.00L |
| General And Administrative Expense | ₹478.90L | ₹461.96L | ₹462.74L | ₹342.36L | ₹0.00L |
| Selling General And Administration | ₹2,202.40L | ₹2,401.26L | ₹2,207.39L | ₹1,819.77L | ₹0.00L |
| Otherunder Preferred Stock Dividend | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Unusual Items Excluding Goodwill | ₹11.30L | ₹1.35L | ₹8.27L | ₹13.29L | ₹0.00L |
| Net Non Operating Interest Income Expense | -₹1,607.12L | -₹1,605.41L | -₹1,410.58L | -₹1,208.25L | ₹0.00L |
| Net Income Including Noncontrolling Interests | ₹632.01L | ₹723.67L | ₹744.57L | ₹261.93L | ₹0.00L |
| Net Income From Continuing And Discontinued Operation | ₹628.36L | ₹721.53L | ₹739.22L | ₹257.17L | ₹0.00L |
| Net Income From Continuing Operation Net Minority Interest | ₹628.36L | ₹721.54L | ₹739.22L | ₹257.17L | ₹0.00L |
Company Performance (FY23–FY26)
₹339.2 Cr₹254.4 Cr₹169.6 Cr₹84.8 Cr₹0
FY23FY24FY25FY26
Directors
| Appointment | Director name | DIN | Designation | |
|---|---|---|---|---|
| 01/08/2004 | Shailesh Siroya | 00048109 | Managing Director | View other directorships |
| 28/09/2019 | Virupakshaya Himesh | 08554422 | Whole-time director | View other directorships |
| 23/05/2020 | Harihara Subramanian Venkatesh | 01776040 | Director | View other directorships |
| 23/05/2020 | Nicola Neeladri | 01997936 | Director | View other directorships |
| 28/12/2020 | Jatish Sheth | 00581963 | Director | View other directorships |
| 30/05/2022 | Chittanand Damodar Kotian | 09613054 | Whole-time director | View other directorships |
| 06/02/2023 | Daddanala Venkat Bharath Bhushan | *****2220C | CFO | |
| 17/07/2023 | Abdul Basith | *****9593B | Company Secretary |
Business Network
CompanyDirectorNot on WeeDooBoard seatKey rolePast seatOwnership
Directors 8
- Shailesh SiroyaManaging Director
- Chittanand Damodar KotianWhole-time director
- Virupakshaya HimeshWhole-time director
- Jatish ShethDirector
- Harihara Subramanian VenkateshDirector
- Nicola NeeladriDirector
- Abdul BasithCompany Secretary
- Daddanala Venkat Bharath BhushanCFO
Latest Documents
Category:
| Date | Title | Size |
|---|---|---|
| 17/12/2024 | Form Addendum to AOC-4 CSR-17122024_signed | - |
| 26/11/2024 | Form MGT-7-20112024 | - |
| 17/10/2024 | Form AOC-4(XBRL)-16102024 | - |
| 25/03/2024 | Form Addendum to AOC-4 CSR-25032024_signed | - |
Similar Companies
| Company | CIN | Address |
|---|---|---|
| A D S Diagnostic Limited | L85110DL1984PLC018486 | 114 Sant Nagar East Of Kailash, New Delhi, Delhi, India, 110065 |
| Amar Diagnostic Centre And Hospital Limited | L85110AP1991PLC012297 | 29-6-29;r.r.road;suryaraopet; Vijayawada; Krishna Dist.; A.p; Andhra Pradesh; 000000; India |
| Emed.com Technologies Limited. | L85110AP1989PLC009748 | 8-2-87-89, 4th Floor, Left Hand Side,srinivasa Plaza,srinagar Colony,main Road,hyderaba, D, Hyderabad, Telangana, India, 500082 |
| Religare Technova Global Solutions Limited | L85110DL1994PLC166888 | 25; Nehru Place; New Delhi; South Delhi; Delhi; 110019; India |
| Thrive Future Habitats Limited | L85110DL1948PLC465696 | - |
Address
21-22, Bommasandra, Industrial Area, Bommasandra Industrial Estate, Bangalore, Bangalore South, Karnataka, India, 560099
Frequently Asked Questions
What is the incorporation date of Bal Pharma Limited?
The incorporation date of Bal Pharma Limited is 19/05/1987.
What is the authorized share capital and paid-up capital of Bal Pharma Limited?
The authorized share capital of Bal Pharma Limited is ₹20,00,00,000.00. The paid-up capital is ₹15,92,08,720.00.
Who are the current board members & directors of Bal Pharma Limited?
The current board member of Bal Pharma Limited are:
- Jatish Sheth
- Jatish Sheth
- Shailesh Siroya
- Virupakshaya Himesh
- Chittanand Damodar Kotian
- Harihara Subramanian Venkatesh
- Nicola Neeladri
What is the registered address of Bal Pharma Limited?
The registered address of Bal Pharma Limited is 21-22, Bommasandra, Industrial Area, Bommasandra Industrial Estate, Bangalore, Bangalore South, Karnataka, India, 560099.
What is the Corporate Identification Number of Bal Pharma Limited?
The Corporate Identification Number of Bal Pharma Limited is L85110KA1987PLC008368.